174 related articles for article (PubMed ID: 12516400)
1. [Expression of autoantibodies to ICA512 and GAD in the sera of patients with diabetic ketoacidosis or ketonemia].
Zhang YJ; Chen HL; Yu LP; Han XY
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):545-7. PubMed ID: 12516400
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
[TBL] [Abstract][Full Text] [Related]
3. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
[TBL] [Abstract][Full Text] [Related]
4. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
[TBL] [Abstract][Full Text] [Related]
5. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
7. Dual-parameter model for prediction of type I diabetes mellitus.
Eisenbarth GS; Gianani R; Yu L; Pietropaolo M; Verge CF; Chase HP; Redondo MJ; Colman P; Harrison L; Jackson R
Proc Assoc Am Physicians; 1998; 110(2):126-35. PubMed ID: 9542768
[TBL] [Abstract][Full Text] [Related]
8. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
10. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
Leslie RD; Atkinson MA; Notkins AL
Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
[No Abstract] [Full Text] [Related]
11. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
12. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation with human recombinant autoantigens.
Lernmark A; Agardh CD
Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
[TBL] [Abstract][Full Text] [Related]
14. Antibodies directed against the ectodomain of ICA512: is there any evidence in patients with diabetes mellitus?
Schiel R
Diabetologia; 1998 Dec; 41(12):64-5. PubMed ID: 9867225
[No Abstract] [Full Text] [Related]
15. Does GAD have a unique role in triggering IDDM?
Baekkeskov S; Kanaani J; Jaume JC; Kash S
J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
[No Abstract] [Full Text] [Related]
16. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
[TBL] [Abstract][Full Text] [Related]
18. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to ICA512/IA-2 in rodent models of IDDM.
Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR
J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975
[TBL] [Abstract][Full Text] [Related]
20. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.
Kulmala P; Rahko J; Savola K; Vähäsalo P; Veijola R; Sjöroos M; Reunanen A; Ilonen J; Knip M
Diabetologia; 2000 Apr; 43(4):457-64. PubMed ID: 10819239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
